All In Biotech

Drug Trial Radar · NCT04832100

Bio-significance of LPC16:0 in Fibromyalgia

A Clinical Approach to Validate the Biological Significance of LPC16:0 as a Discriminating and Pathogenic Biomarker of Fibromyalgia

Last checked: Nov 20, 2026Latest source record: Jun 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

245

Planned (sponsor's estimate)

Start

Jun 1, 2021

Primary completion

Jun 30, 2026

Study completion Jun 30, 2027

Sponsor

Lead sponsor
Kaohsiung Medical University Chung-Ho Memorial HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 5, 2021

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years

Summary

As written by the sponsor on the registry.

Fibromyalgia (FM) is a very common but mysterious pain disorder characterized by chronic widespread muscular pain. Fatigue, anxiety and depression are common comorbidities. The syndrome is commonly associated with several symptoms, including fatigue, sleeping disturbance, cognitive impairment, and comorbid pain syndrome, especially irritable bowel symptoms and temporomandibular disease. Anxiety and depression are common psychiatric co-morbidies. Daily stress is believed to trigger or aggravate pain conditions. These symptoms can markedly affect patients' quality of life, and even lead to disability. So far, the etiology and pathogenesis are largely unknown, and diagnostic biomarkers and curative treatment remain to be developed. Recent technological advances enable scientists to explore mechanisms by genetic, transcriptomic, proteomic, and metabolomic researches. However, no definitive result has been concluded for clinical practice so far. In this study, the investigators use tailored questionnaires to evaluate fibromyalgia and associated symptoms, including numeric rating scale for soreness, widespread soreness index, Fibromyalgia impact questionnaire, Hospital Anxiety and Depression Scale, and perceived stress scale. The investigators also use metabolomics and lipidomic approach to probe the potential pathophysiology of fibromyalgia. In our prior translation research (PMID: 32907805), the investigators found that excessive LPC16:0 resulting from lipid oxidization inflicts psychological stress-induced chronic non-inflammatory pain via activating ASIC3. In this content, our prior translational research identified a potential nociceptive ligand that causes fibromyalgia symptoms, which is likely to function as biomarkers for diagnosis or disease monitor. In the current clinical investigation, the investigators aim to reversely translate the novel findings in animal studies and validate the bio-significance of LPC16:0 for fibromyalgia with clinical approaches.

Conditions

  • Fibromyalgia, Primary
  • Pain
  • Soreness, Muscle
  • Oxidative Stress
  • Metabolomics
  • Lipidomics

Interventions

  • Pregabalin 150mg, imipramine 25mgDrug

    Conventional treatment for fibromyalgia was given to patients. Clinical follow-ups with questionnaires and interview were arranged then.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Questionnaire: Numeric rating scale (NRS) for pain and sorenessTime frame: Changes from baseline NRS at 2 weeks are assessed
  2. Questionnaire: Numeric rating scale (NRS) for pain and sorenessTime frame: Changes from baseline NRS at 4 weeks are assessed
  3. Questionnaire: widespread pain index and widespread soreness indexTime frame: Change from baseline widespread index at 2 weeks are assessed
  4. Questionnaire: widespread pain index and widespread soreness indexTime frame: Change from baseline widespread index at 4 weeks are assessed
  5. Questionnaire: Fibromyalgia impact questionnaire (FIQR)Time frame: Change from baseline FIQR at 2 weeks are assessed
  6. Questionnaire: Fibromyalgia impact questionnaire (FIQR)Time frame: Change from baseline FIQR at 4 weeks are assessed
  7. Questionnaire: Hospital Anxiety and Depression Scale (HADS)Time frame: Change from baseline HADS at 2 weeks are assessed
  8. Questionnaire: Hospital Anxiety and Depression Scale (HADS)Time frame: Change from baseline HADS at 4 weeks are assessed
  9. Questionnaire: The Pittsburgh Sleep Quality Index (PSQI)Time frame: Change from baseline PSQI at 2 weeks are assessed
  10. Questionnaire: The Pittsburgh Sleep Quality Index (PSQI)Time frame: Change from baseline PSQI at 4 weeks are assessed
  11. Questionnaire: Perceived stress scale (PSS)Time frame: Change from baseline PSS at 2 weeks are assessed
  12. Questionnaire: Perceived stress scale (PSS)Time frame: Change from baseline PSS at 4 weeks are assessed
  13. Metabolomics investigationTime frame: Change from baseline metabolomics at 3 months are assessed
  14. Lipidomics investigationTime frame: Change from baseline metabolomics at 3 months are assessed
  15. Metabolomics investigationTime frame: Change from baseline metabolomics at 6 months are assessed
  16. Lipidomics investigationTime frame: Change from baseline metabolomics at 6 months are assessed
  17. Metabolomics investigationTime frame: Change from baseline metabolomics at 9 months are assessed
  18. Lipidomics investigationTime frame: Change from baseline metabolomics at 9 months are assessed
  19. Metabolomics investigationTime frame: Change from baseline metabolomics at 12 months are assessed
  20. Lipidomics investigationTime frame: Change from baseline metabolomics at 12 months are assessed

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Kaohsiung Medical University Hospital

    Kaohsiung City, Taiwan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.